| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 3.04e-08 | 6 | 24 | 3 | GO:0008510 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51B5 OR51G1 GPR50 GRM4 OR2F1 GRM8 GPR142 OR51B6 OR51B2 OR51I2 | 3.06e-08 | 884 | 24 | 10 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51B5 OR51G1 GPR50 PTPRG GRM4 OR2F1 GRM8 GPR142 OR51B6 OR51B2 OR51I2 | 1.46e-07 | 1353 | 24 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 4.33e-07 | 13 | 24 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.51e-06 | 81 | 24 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | sodium,bicarbonate:chloride antiporter activity | 4.15e-06 | 3 | 24 | 2 | GO:0140892 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 7.40e-06 | 32 | 24 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 7.40e-06 | 32 | 24 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 8.29e-06 | 4 | 24 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 9.45e-06 | 431 | 24 | 6 | GO:0004984 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.16e-05 | 119 | 24 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.33e-05 | 296 | 24 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | symporter activity | 2.89e-05 | 150 | 24 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.97e-05 | 151 | 24 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.83e-05 | 171 | 24 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.83e-05 | 171 | 24 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 4.96e-05 | 9 | 24 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 4.96e-05 | 9 | 24 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.07e-04 | 13 | 24 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.07e-04 | 13 | 24 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.22e-04 | 477 | 24 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.83e-04 | 293 | 24 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 4.24e-04 | 301 | 24 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.40e-04 | 125 | 24 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.77e-04 | 27 | 24 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | antiporter activity | 5.88e-04 | 138 | 24 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.21e-03 | 43 | 24 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.13e-03 | 465 | 24 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.25e-03 | 1180 | 24 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 3.51e-03 | 1289 | 24 | 6 | GO:0005215 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 4.44e-03 | 83 | 24 | 2 | GO:0015101 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 6.20e-03 | 627 | 24 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 7.58e-03 | 664 | 24 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.19e-02 | 758 | 24 | 4 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.39e-02 | 793 | 24 | 4 | GO:0015075 | |
| GeneOntologyBiologicalProcess | sensory perception | SLC4A10 SLC6A3 OR51B5 SLC4A7 OR51G1 OR2F1 GRM8 OR51B6 OR51B2 OR51I2 | 2.20e-07 | 1072 | 25 | 10 | GO:0007600 |
| GeneOntologyBiologicalProcess | sensory perception of smell | 9.57e-07 | 465 | 25 | 7 | GO:0007608 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51B5 OR51G1 GPR50 GRM4 OR2F1 GRM8 GPR142 OR51B6 OR51B2 OR51I2 | 2.48e-06 | 1395 | 25 | 10 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 2.82e-06 | 547 | 25 | 7 | GO:0007606 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 4.24e-06 | 582 | 25 | 7 | GO:0050906 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 1.03e-05 | 432 | 25 | 6 | GO:0050911 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 1.29e-05 | 38 | 25 | 3 | GO:0015701 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 1.73e-05 | 722 | 25 | 7 | GO:0051606 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 1.98e-05 | 485 | 25 | 6 | GO:0050907 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 3.07e-05 | 524 | 25 | 6 | GO:0009593 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 5.05e-05 | 9 | 25 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.08e-04 | 208 | 25 | 4 | GO:0035725 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 1.67e-04 | 16 | 25 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 1.96e-04 | 94 | 25 | 3 | GO:0051453 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 2.42e-04 | 101 | 25 | 3 | GO:0030641 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 2.50e-04 | 259 | 25 | 4 | GO:0006836 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.14e-04 | 275 | 25 | 4 | GO:0006814 | |
| GeneOntologyBiologicalProcess | locomotory exploration behavior | 3.21e-04 | 22 | 25 | 2 | GO:0035641 | |
| GeneOntologyBiologicalProcess | regulation of pH | 4.02e-04 | 120 | 25 | 3 | GO:0006885 | |
| GeneOntologyBiologicalProcess | rescue of stalled ribosome | 7.73e-04 | 34 | 25 | 2 | GO:0072344 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.17e-04 | 153 | 25 | 3 | GO:0098656 | |
| GeneOntologyBiologicalProcess | ribosome disassembly | 1.18e-03 | 42 | 25 | 2 | GO:0032790 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.31e-03 | 180 | 25 | 3 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.37e-03 | 183 | 25 | 3 | GO:0006820 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.64e-03 | 195 | 25 | 3 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.64e-03 | 195 | 25 | 3 | GO:0007269 | |
| GeneOntologyBiologicalProcess | exploration behavior | 1.67e-03 | 50 | 25 | 2 | GO:0035640 | |
| GeneOntologyCellularComponent | axon terminus | 1.06e-04 | 210 | 25 | 4 | GO:0043679 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.58e-04 | 233 | 25 | 4 | GO:0044306 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.06e-04 | 277 | 25 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.29e-04 | 320 | 25 | 4 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 7.72e-04 | 354 | 25 | 4 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 9.85e-04 | 378 | 25 | 4 | GO:0045178 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 1.20e-03 | 43 | 25 | 2 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 1.44e-03 | 47 | 25 | 2 | GO:0044298 | |
| GeneOntologyCellularComponent | distal axon | 1.65e-03 | 435 | 25 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | presynapse | 3.54e-03 | 886 | 25 | 5 | GO:0098793 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.90e-03 | 78 | 25 | 2 | GO:0048787 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.75e-03 | 583 | 25 | 4 | GO:0097060 | |
| GeneOntologyCellularComponent | terminal bouton | 5.85e-03 | 96 | 25 | 2 | GO:0043195 | |
| GeneOntologyCellularComponent | cytosolic ribosome | 9.58e-03 | 124 | 25 | 2 | GO:0022626 | |
| Domain | ANION_EXCHANGER_2 | 7.39e-08 | 7 | 25 | 3 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 7.39e-08 | 7 | 25 | 3 | PS00219 | |
| Domain | - | 1.77e-07 | 9 | 25 | 3 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.77e-07 | 9 | 25 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 1.77e-07 | 9 | 25 | 3 | PF07565 | |
| Domain | HCO3_transpt_C | 2.53e-07 | 10 | 25 | 3 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 2.53e-07 | 10 | 25 | 3 | IPR016152 | |
| Domain | HCO3_cotransp | 2.53e-07 | 10 | 25 | 3 | PF00955 | |
| Domain | HCO3_transpt_euk | 2.53e-07 | 10 | 25 | 3 | IPR003020 | |
| Domain | GPCR_Rhodpsn_7TM | 1.66e-06 | 670 | 25 | 8 | IPR017452 | |
| Domain | 7tm_1 | 1.79e-06 | 677 | 25 | 8 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.95e-06 | 685 | 25 | 8 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.08e-06 | 691 | 25 | 8 | PS50262 | |
| Domain | GPCR_Rhodpsn | 2.11e-06 | 692 | 25 | 8 | IPR000276 | |
| Domain | Olfact_rcpt | 1.05e-05 | 393 | 25 | 6 | IPR000725 | |
| Domain | Anion_exchange | 1.72e-05 | 5 | 25 | 2 | IPR001717 | |
| Domain | Na/HCO3_transpt | 1.72e-05 | 5 | 25 | 2 | IPR003024 | |
| Domain | GPCR_3_mtglu_rcpt | 4.79e-05 | 8 | 25 | 2 | IPR000162 | |
| Domain | GPCR_3_9-Cys_dom | 1.33e-04 | 13 | 25 | 2 | IPR011500 | |
| Domain | NCD3G | 1.33e-04 | 13 | 25 | 2 | PF07562 | |
| Domain | GPCR_3_CS | 1.55e-04 | 14 | 25 | 2 | IPR017979 | |
| Domain | GPCR_3 | 3.56e-04 | 21 | 25 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 3.91e-04 | 22 | 25 | 2 | PS50259 | |
| Domain | 7tm_3 | 3.91e-04 | 22 | 25 | 2 | PF00003 | |
| Domain | GPCR_3_C | 3.91e-04 | 22 | 25 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 3.91e-04 | 22 | 25 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 3.91e-04 | 22 | 25 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 3.91e-04 | 22 | 25 | 2 | PS00979 | |
| Domain | ANF_receptor | 1.11e-03 | 37 | 25 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 1.11e-03 | 37 | 25 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 1.24e-03 | 39 | 25 | 2 | IPR028082 | |
| Domain | MFS | 4.73e-03 | 77 | 25 | 2 | IPR011701 | |
| Domain | MFS_1 | 4.73e-03 | 77 | 25 | 2 | PF07690 | |
| Domain | Prot-tyrosine_phosphatase-like | 7.71e-03 | 99 | 25 | 2 | IPR029021 | |
| Domain | MFS | 9.11e-03 | 108 | 25 | 2 | PS50850 | |
| Domain | 7TM_GPCR_Srsx | 9.77e-03 | 112 | 25 | 2 | SM01381 | |
| Domain | MFS_dom | 1.38e-02 | 134 | 25 | 2 | IPR020846 | |
| Domain | fn3 | 1.97e-02 | 162 | 25 | 2 | PF00041 | |
| Domain | FN3 | 2.52e-02 | 185 | 25 | 2 | SM00060 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 4.52e-07 | 10 | 23 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 4.52e-07 | 10 | 23 | 3 | MM15073 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.58e-05 | 108 | 23 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.67e-05 | 109 | 23 | 4 | MM15074 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 2.88e-05 | 389 | 23 | 6 | M14091 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.45e-05 | 238 | 23 | 5 | MM15076 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 4.25e-05 | 417 | 23 | 6 | M4072 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.28e-05 | 249 | 23 | 5 | M5988 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 4.79e-05 | 636 | 23 | 7 | M41834 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.64e-04 | 15 | 23 | 2 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.64e-04 | 15 | 23 | 2 | MM15845 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 6.19e-04 | 681 | 23 | 6 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 9.32e-04 | 736 | 23 | 6 | M27287 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.64e-03 | 37 | 23 | 2 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.82e-03 | 39 | 23 | 2 | M793 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 2.70e-03 | 367 | 23 | 4 | M48346 | |
| Pubmed | 2.82e-10 | 15 | 25 | 4 | 11121057 | ||
| Pubmed | 2.82e-10 | 15 | 25 | 4 | 10220430 | ||
| Pubmed | 3.28e-09 | 5 | 25 | 3 | 23500099 | ||
| Pubmed | K+-Driven Cl-/HCO3- Exchange Mediated by Slc4a8 and Slc4a10. | 4.96e-07 | 2 | 25 | 2 | 38674160 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17928512 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 33068816 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 12444018 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 9473604 | ||
| Pubmed | Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic anhydrase II and PKA. | 1.49e-06 | 3 | 25 | 2 | 14736710 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 20018918 | ||
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 2.11e-06 | 35 | 25 | 3 | 16939646 | |
| Pubmed | 2.72e-06 | 38 | 25 | 3 | 22908908 | ||
| Pubmed | Distribution of group-III metabotropic glutamate receptors in the retina. | 2.97e-06 | 4 | 25 | 2 | 17311335 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 14592810 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 12403779 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 20133774 | ||
| Pubmed | Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues. | 2.97e-06 | 4 | 25 | 2 | 17715183 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 3.92e-06 | 340 | 25 | 5 | 11875048 | |
| Pubmed | 3.92e-06 | 340 | 25 | 5 | 11802173 | ||
| Pubmed | 4.09e-06 | 343 | 25 | 5 | 32295537 | ||
| Pubmed | 4.27e-06 | 346 | 25 | 5 | 14611657 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 27539848 | ||
| Pubmed | Early Hearing Loss upon Disruption of Slc4a10 in C57BL/6 Mice. | 7.43e-06 | 6 | 25 | 2 | 31001720 | |
| Pubmed | Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. | 7.43e-06 | 6 | 25 | 2 | 16144832 | |
| Pubmed | Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. | 7.43e-06 | 6 | 25 | 2 | 8824806 | |
| Pubmed | The actin-binding protein Filamin-A interacts with the metabotropic glutamate receptor type 7. | 7.43e-06 | 6 | 25 | 2 | 11943148 | |
| Pubmed | Genetic mapping and exome sequencing identify variants associated with five novel diseases. | 1.04e-05 | 7 | 25 | 2 | 22279524 | |
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 2.22e-05 | 10 | 25 | 2 | 9069281 | |
| Pubmed | 2.22e-05 | 10 | 25 | 2 | 17156446 | ||
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 21705333 | ||
| Pubmed | 5.92e-05 | 16 | 25 | 2 | 36049479 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 8.29e-05 | 118 | 25 | 3 | 19156168 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.36e-04 | 24 | 25 | 2 | 35746896 | |
| Pubmed | The transcriptome of human CD34+ hematopoietic stem-progenitor cells. | 2.13e-04 | 30 | 25 | 2 | 19416867 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 2.48e-04 | 171 | 25 | 3 | 20201926 | |
| Pubmed | 2.58e-04 | 33 | 25 | 2 | 17350283 | ||
| Pubmed | 4.82e-04 | 45 | 25 | 2 | 25979088 | ||
| Pubmed | 5.65e-04 | 541 | 25 | 4 | 14983052 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 6.82e-04 | 569 | 25 | 4 | 30639242 | |
| Cytoband | 11p15.4 | 4.12e-06 | 200 | 25 | 4 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.19e-05 | 564 | 25 | 5 | chr11p15 | |
| GeneFamily | Olfactory receptors, family 51 | 2.77e-09 | 44 | 24 | 5 | 164 | |
| GeneFamily | Solute carriers | 1.01e-05 | 395 | 24 | 6 | 752 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 4.71e-05 | 8 | 24 | 2 | 281 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 4.77e-03 | 78 | 24 | 2 | 262 | |
| GeneFamily | Fibronectin type III domain containing | 1.89e-02 | 160 | 24 | 2 | 555 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.69e-05 | 116 | 25 | 3 | eb340d6c422adfc4bf861ab16c35819b315b61fa | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.42e-05 | 132 | 25 | 3 | 6a6718582edfc59c63f2c8f753be81e0f4a7246b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.16e-05 | 145 | 25 | 3 | 734d85ca7a2e5e040f433cadc5f9be1f25cf2e91 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.16e-05 | 145 | 25 | 3 | 8ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 147 | 25 | 3 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 147 | 25 | 3 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-05 | 153 | 25 | 3 | 0b3b199678d4a70b0590393568c69454bece5c14 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-04 | 168 | 25 | 3 | 4a2e08b047f7170ae4b95eac9b2b128e55beee4a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-04 | 168 | 25 | 3 | 3e09516e819cf140a6dbf8f85247d3f08aa35bb8 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 1.11e-04 | 168 | 25 | 3 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 1.13e-04 | 169 | 25 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 169 | 25 | 3 | d0c64ca31053dfc283a07d5ad1117ca7dc1777a7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 169 | 25 | 3 | d79abfbeffd082a4fbffbc1051ffc474374874fa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 171 | 25 | 3 | 0417fa805ca0acb7e9f6a30bc7b6bdbaba77844d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-04 | 173 | 25 | 3 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 175 | 25 | 3 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_THEMIS_ELOF1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 176 | 25 | 3 | 78306517b1e52411a2ba72f141efea4d12c09f25 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 176 | 25 | 3 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 177 | 25 | 3 | fbead6e56271b1f1d447f89857de444ebe7157b0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 177 | 25 | 3 | a25ca82c4bda033ee113f8ecb4a541b22e7a29ca | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 178 | 25 | 3 | b0fc56f583cb3f2977fe2306994c0d478c9a6b1b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 179 | 25 | 3 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 25 | 3 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 193 | 25 | 3 | 44ba79db566d0fa3bbcfe3adf9164bf8c3cb0bc3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 193 | 25 | 3 | f92bbe70e6c725bfb8c08bfc2a94e375528151a3 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-04 | 194 | 25 | 3 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | mLN-T_cell-gd_T|mLN / Region, Cell class and subclass | 1.77e-04 | 197 | 25 | 3 | 8ef03bdbd34a874671aebfdbb7111106aa37b2a9 | |
| ToppCell | mLN-(1)_T_cell-(17)_gd_T|mLN / shred on region, Cell_type, and subtype | 1.77e-04 | 197 | 25 | 3 | 5c781ded147db2f3804ee1f21ef0898c4f354890 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 1b485ff2435c6732be58cbc9eb2f5c273f9c4bf2 | |
| Drug | 1-amino-2-phosphonomethylcyclopropanecarboxylic acid | 3.47e-06 | 3 | 25 | 2 | ctd:C523415 | |
| Drug | butriptyline | 6.94e-06 | 4 | 25 | 2 | CID000021771 | |
| Drug | AC1MBZ3L | 1.73e-05 | 6 | 25 | 2 | CID002733524 | |
| Drug | cis-MCG-I | 3.23e-05 | 8 | 25 | 2 | CID003035584 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 4.04e-05 | 61 | 25 | 3 | CID000003868 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 4.15e-05 | 9 | 25 | 2 | CID000107216 | |
| Drug | mM PEP | 4.15e-05 | 9 | 25 | 2 | CID005311462 | |
| Drug | AC1N21PP | 4.15e-05 | 9 | 25 | 2 | CID004014619 | |
| Drug | NS-105 | 5.18e-05 | 10 | 25 | 2 | CID000198695 | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 3986_DN | |
| Drug | cyclobutylene AP5 | 6.33e-05 | 11 | 25 | 2 | CID000126582 | |
| Drug | AC1NSKBB | 8.96e-05 | 13 | 25 | 2 | CID005311256 | |
| Drug | Mspg | 8.96e-05 | 13 | 25 | 2 | CID003964410 | |
| Drug | MSOPPE | 8.96e-05 | 13 | 25 | 2 | CID005311463 | |
| Drug | 2-methyl-6-styrylpyridine | 1.04e-04 | 14 | 25 | 2 | CID000235382 | |
| Drug | MTPG | 1.04e-04 | 14 | 25 | 2 | CID005311456 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.04e-04 | 14 | 25 | 2 | ctd:C012729 | |
| Drug | ethylglutamate | 1.38e-04 | 16 | 25 | 2 | CID000014241 | |
| Drug | 2-PMPA | 1.38e-04 | 16 | 25 | 2 | CID010130754 | |
| Drug | 3HPG | 1.56e-04 | 17 | 25 | 2 | CID000001217 | |
| Drug | acromelic acid A | 1.75e-04 | 18 | 25 | 2 | CID000108086 | |
| Drug | aminocyclopentane | 1.96e-04 | 19 | 25 | 2 | CID000002906 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 2.17e-04 | 20 | 25 | 2 | CID000001297 | |
| Drug | 3,4-dihydroxyphenylglycine | 2.40e-04 | 21 | 25 | 2 | CID000027915 | |
| Drug | Thallium | 2.64e-04 | 22 | 25 | 2 | ctd:D013793 | |
| Drug | MSOP | 2.89e-04 | 23 | 25 | 2 | CID003964633 | |
| Drug | Lowicryl HM20 | 2.89e-04 | 23 | 25 | 2 | CID000174488 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 3.15e-04 | 24 | 25 | 2 | CID003645780 | |
| Drug | AC1NQH9B | 3.70e-04 | 26 | 25 | 2 | CID005221504 | |
| Drug | HEPES | 4.35e-04 | 136 | 25 | 3 | CID000023830 | |
| Drug | sodium | 4.50e-04 | 944 | 25 | 6 | CID000000923 | |
| Drug | AC1L2E5V | 4.61e-04 | 29 | 25 | 2 | CID000019458 | |
| Drug | PBDA | 4.94e-04 | 30 | 25 | 2 | CID000004408 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 5.63e-04 | 32 | 25 | 2 | CID000001222 | |
| Drug | Methyl-1 (S-methylphosphoryl-3) imidazolium | 5.91e-04 | 151 | 25 | 3 | CID000051213 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 5.99e-04 | 33 | 25 | 2 | CID000002071 | |
| Drug | H2DIDS | 5.99e-04 | 33 | 25 | 2 | CID000115184 | |
| Drug | CPPG | 6.36e-04 | 34 | 25 | 2 | CID000002878 | |
| Drug | 1m5d | 6.74e-04 | 35 | 25 | 2 | CID000447082 | |
| Drug | MPTP-HCl | 7.25e-04 | 162 | 25 | 3 | CID000001388 | |
| Drug | gamma-Glu-Gly | 7.53e-04 | 37 | 25 | 2 | CID000100099 | |
| Drug | benzyloxyaspartate | 7.53e-04 | 37 | 25 | 2 | CID004133412 | |
| Drug | AC1L9M3Z | 7.94e-04 | 38 | 25 | 2 | CID000448575 | |
| Drug | L-BMAA | 7.94e-04 | 38 | 25 | 2 | CID000028558 | |
| Drug | 4CPG | 7.94e-04 | 38 | 25 | 2 | CID000005115 | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 8.37e-04 | 39 | 25 | 2 | CID003331970 | |
| Drug | DETC-MeSO | 8.37e-04 | 39 | 25 | 2 | CID003035711 | |
| Drug | Aspartylglutamate | 8.80e-04 | 40 | 25 | 2 | CID000151403 | |
| Drug | L000369 | 9.25e-04 | 41 | 25 | 2 | CID003931705 | |
| Drug | AC1NNRU4 | 9.25e-04 | 41 | 25 | 2 | CID005126051 | |
| Drug | butenafine | 9.70e-04 | 42 | 25 | 2 | CID000002484 | |
| Drug | phencyclidine | 9.99e-04 | 181 | 25 | 3 | CID000006468 | |
| Drug | LY341495 | 1.02e-03 | 43 | 25 | 2 | CID006324636 | |
| Drug | Joro spider toxin | 1.02e-03 | 43 | 25 | 2 | CID000119582 | |
| Drug | cysteine sulfinic acid | 1.16e-03 | 46 | 25 | 2 | CID000000109 | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; HL60; HG-U133A | 1.17e-03 | 191 | 25 | 3 | 1761_UP | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 4551_UP | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.26e-03 | 196 | 25 | 3 | 3206_DN | |
| Drug | phorbol 12,13-diacetate | 1.27e-03 | 48 | 25 | 2 | CID000072293 | |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; PC3; HT_HG-U133A | 1.28e-03 | 197 | 25 | 3 | 4009_DN | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; PC3; HT_HG-U133A | 1.29e-03 | 198 | 25 | 3 | 4021_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.29e-03 | 198 | 25 | 3 | 5409_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.31e-03 | 199 | 25 | 3 | 6624_DN | |
| Drug | methylenecyclopropylglycine | 1.32e-03 | 49 | 25 | 2 | CID000441452 | |
| Disease | anemia (implicated_via_orthology) | 1.63e-07 | 15 | 22 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | sickle cell anemia | 1.48e-05 | 8 | 22 | 2 | MONDO_0011382 | |
| Disease | inferior parietal cortex volume measurement | 9.00e-05 | 19 | 22 | 2 | EFO_0010307 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 1.00e-04 | 20 | 22 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | fetal hemoglobin measurement | 1.10e-04 | 21 | 22 | 2 | EFO_0004576 | |
| Disease | Minimal Brain Dysfunction | 1.21e-04 | 22 | 22 | 2 | C1321905 | |
| Disease | Attention Deficit Disorder | 1.21e-04 | 22 | 22 | 2 | C0041671 | |
| Disease | Attention deficit hyperactivity disorder | 1.45e-04 | 24 | 22 | 2 | C1263846 | |
| Disease | smoking status measurement | 1.58e-04 | 1160 | 22 | 6 | EFO_0006527 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder | 2.44e-04 | 31 | 22 | 2 | EFO_0003888, MONDO_0004985 | |
| Disease | Anxiety neurosis (finding) | 4.93e-04 | 44 | 22 | 2 | C1279420 | |
| Disease | Anxiety Disorders | 4.93e-04 | 44 | 22 | 2 | C0003469 | |
| Disease | Anxiety States, Neurotic | 4.93e-04 | 44 | 22 | 2 | C0376280 | |
| Disease | frontal fibrosing alopecia | 5.86e-04 | 48 | 22 | 2 | EFO_0009855 | |
| Disease | obsolete aging | 1.13e-03 | 279 | 22 | 3 | GO_0007568 | |
| Disease | Nerve Degeneration | 1.74e-03 | 83 | 22 | 2 | C0027746 | |
| Disease | sodium measurement | 2.66e-03 | 103 | 22 | 2 | EFO_0009282 | |
| Disease | Schizophrenia | 3.79e-03 | 883 | 22 | 4 | C0036341 | |
| Disease | neuroticism measurement | 4.20e-03 | 909 | 22 | 4 | EFO_0007660 | |
| Disease | Bipolar Disorder | 5.14e-03 | 477 | 22 | 3 | C0005586 | |
| Disease | Mood Disorders | 6.91e-03 | 168 | 22 | 2 | C0525045 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 9.11e-03 | 194 | 22 | 2 | EFO_0004265, EFO_0007908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETIYHPPIMNYMISY | 371 | P23470 | |
| LRNPMEAMYPHIFYF | 201 | Q96AK3 | |
| MLYMPKVYIILFHPE | 836 | Q14833 | |
| VYHMLYKLMPELPQY | 1401 | O94822 | |
| TLMYPFFYRPMFEVI | 106 | Q96QG7 | |
| LVAIYPYPLMLHAMS | 76 | Q13585 | |
| HIIMSYIYFLFPPLM | 271 | Q9Y5P1 | |
| HLIMSYAYFLFPPLM | 271 | Q9H339 | |
| HITMSYIHFLFPPFM | 271 | Q9H340 | |
| LFMSYVYLLVPPLMN | 276 | Q8NGK1 | |
| VEPSLHEPMYYFLSM | 51 | Q9H344 | |
| VFYAILTPMLNPMIY | 276 | Q13607 | |
| GMLYMPKVYIIIFHP | 831 | O00222 | |
| MASYIPLFPQLYFHM | 256 | B0YJ81 | |
| MVYMLAYVPLIFPAT | 151 | Q9Y5Y0 | |
| APRVFVMLYHMYVAP | 371 | Q7Z601 | |
| PMSSYMPIVLFLIVY | 1011 | Q9P232 | |
| FIPMPVLYGVFLYMG | 1031 | Q9Y6M7 | |
| YELMFHVSTLLPYMP | 676 | Q9P2F8 | |
| FIPMPVLYGVFLYMG | 901 | Q2Y0W8 | |
| PYLLFMVIAGMPLFY | 101 | Q01959 | |
| KFIPMPVLYGVFLYM | 931 | Q6U841 | |
| YRPHLAPMSIYEVMY | 486 | P42681 | |
| CPPMYHLMKFIPLYS | 436 | Q14694 | |
| PLALFGYFVPYVHLM | 301 | Q8TF71 |